Solvias – Supporting the research and development of drug substances and the optimization of manufacturing processes for pharmaceutical, biotechnology and life sciences companies worldwide.

We are a privately held company located in Basel, Switzerland, with over 280 highly qualified employees. Leveraging our proven expertise and experience, we develop flexible, customized solutions that meet your specific drug-development criteria. Solvias customers benefit from a wide range of experience in the following areas:

Analytical services: Method development, validation and release testing with broad technology base. Services are also available for highly active and cytotoxic compounds.
Analysis of biopharmaceuticals: proteins, peptide- and DNA based therapeutics as well as molecular biology services.
Catalysis solutions: asymmetric synthesis, chiral ligands, HTS catalysis screening, CX-coupling.
Chemical development: Process research and development, synthesis, process redesign and kilo production of APIs under GMP and non-GMP.
Solid-state development: Pre-formulation activities, Polymorphism investigation, salt and co-crystal screening, best form selection and crystallization optimization.
Process analytical technology (PAT): Inprocess controls for process optimizations in chemical and pharmaceutical production plants based on spectroscopic methods.
Patent and search services: prosecution and administration of patents, patent opinion, patent and literature searches.

All analytical services are cGMP-approved by the FDA and Swiss authorities.

Our Goldsponsors

Solvias – Supporting the research and development of drug substances and the optimization of manufacturing processes for pharmaceutical, biotechnology and life sciences companies worldwide.